Nora Therapeutics
Signal active
Organization
Contact Information
Overview
Nora Therapeutics is a specialty biopharmaceutical company focused on developing therapeutics to address clinical unmet needs in reproductive medicine.
Nora’s lead compound, NT100, is a novel treatment being studied to improve pregnancy success rates and outcomes for women who have undergone multiple unsuccessful in vitro fertilization (IVF) procedures. NT100 is a novel biologic agent similar to a naturally occurring protein in the female reproductive tract. NT100’s mechanism of action may better enable embryo implantation and pregnancy maintenance by optimizing maternal-fetal immune tolerance.
About
Industries
Biotechnology, Health Care, Medical Device
Founded
2007
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Nora Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device sector. The company focuses on Biotechnology and has secured $1.8B in funding across 48 round(s). With a team of 11-50 employees, Nora Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Nora Therapeutics, raised $2.9M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
0
Lead Investors
0
Total Funding Amount
$36.8M
Details
4
Nora Therapeutics has raised a total of $36.8M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2009 | Seed | 1.0M | ||
| 2010 | Early Stage Venture | 14.9M | ||
| 2014 | Early Stage Venture | 18.0M | ||
| 2010 | Seed | 2.9M |
Investors
Nora Therapeutics is funded by 3 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Chen Yu | - | FUNDING ROUND - Chen Yu | 18.0M |
| Nora Therapeutics | - | FUNDING ROUND - Nora Therapeutics | 18.0M |
| Vivo Capital | - | FUNDING ROUND - Vivo Capital | 18.0M |
Recent Activity
There is no recent news or activity for this profile.